DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The first product under development, ReViVox™ is based on a clinically validated drug currently approved for a different medical use and route of administration. The novel formulation will manage undesirable side effects resulting from neurotoxin injections in both medical and cosmetic applications.
– Apple
– Spotify
Mark Twain famously said “The reports of my death are greatly exaggerated.” Such is the…
Palantir is not exactly a household name, but the Peter Thiel founded company now based…
Triple Tree and Bain & Co are two very sharp private equity firms and when…
AngelMD is a large and growing healthcare innovation community connecting clinicians, startups, investors, Industry and other stakeholders.
AngelMD is a large and growing healthcare innovation community centered around clinician & startups with tools & education for both.